Lombard Odier Asset Management (Usa) Corp Gilead Sciences, Inc. Put Options Transaction History

Lombard Odier Asset Management (Usa) Corp

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $17.9 Million - $21.8 Million	250,000 New	250,000 $18.3 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $3.26 Million - $3.78 Million	45,000 Added 75.0%	105,000 $8.08 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.76 Million - $4.81 Million	60,000 New	60,000 $4.49 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.